Compounded tirzepatide, another medication PlexusDx offers at $289/mo month-to-month, or from $249/mo on the 6-month plan, provides dual GLP-1 and GIP receptor activation studied in the SURMOUNT trials
By Payer Type, Private and Self-Pay Segment Accounts for 70% Market Share Private insurance and self-pay arrangements are projected to contribute 70% of the market in 2025, representing patients who access treatment through commercial health insurance or direct cash payment
Semaglutide and tirzepatide use standard bacteriostatic water
An experimental drug called petrelintide that offers clinically meaningful weight loss with relatively few stomach issues is making its way through the research pipeline
Pogribna M, Melnyk S, Pogribny I, Chango A, Yi P, James SJ